Risk of new-onset diabetes varies with different statins

April 11, 2013
Risk of new-onset diabetes varies with different statins
Different types and doses of statins seem to correlate with distinct risks of developing new-onset diabetes mellitus, according to a meta-analysis published in the April 15 issue of The American Journal of Cardiology.

(HealthDay)—Different types and doses of statins seem to correlate with distinct risks of developing new-onset diabetes mellitus (DM), according to a meta-analysis published in the April 15 issue of The American Journal of Cardiology.

Eliano Pio Navarese, M.D., Ph.D., of Nicolaus Copernicus University in Poland, and colleagues conducted a network meta-analysis of 17 randomized, controlled trials involving 113,394 patients to examine the impact of different types and doses of statins on new-onset DM.

The researchers found that, in the comparison of statins versus , the lowest risk for new-onset DM was seen for plavastatin 40 mg/day (odds ratio, 1.07; 95 percent credible interval, 0.86 to 1.30). In contrast, 20 mg/day correlated with a greater risk of DM (odds ratio, 1.25; 95 percent credible interval, 0.82 to 1.90), while 80 mg/day exhibited intermediate risk (odds ratio, 1.15; 95 percent credible interval, 0.90 to 1.50). Similar findings were seen at moderate doses of statins.

"The findings of this large network meta-analysis are the first to provide information on the specific risk for DM associated with different types and doses of statins," the authors write. "If the findings of this network meta-analysis were confirmed in powered head-to-head comparisons, they would have important implications for the future management of millions of individuals receiving statins worldwide; indeed, a new scenario of statin therapy could be envisaged in which personalized statin therapy might emerge as the most effective and safest strategy."

Explore further: Statin use in postmenopausal women associated with increased diabetes risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Statins are unlikely to prevent blood clots, analysis finds

September 18, 2012

Despite previous studies suggesting the contrary, statins (cholesterol-lowering drugs) may not prevent blood clots (venous thrombo-embolism) in adults, according to a large analysis by international researchers published ...

Recommended for you

Scientists developing new test for breast cancer

September 29, 2016

Scientists at The Australian National University (ANU) are working with researchers in France to develop a new potential way to detect and monitor breast cancer that could involve a simple blood test.

Tumor paint brings light to toddler's brain tumor

September 28, 2016

In December of last year, Laura Coffman began to notice that something wasn't quite right with her 2-year-old son, Hunter. He was leaning to one side and seemed to lose his balance easily. When he became lethargic and started ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.